Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;46(6):947-56.
doi: 10.1016/j.jpainsymman.2013.01.012. Epub 2013 Apr 28.

Validation of the Edmonton Symptom Assessment System in Korean patients with cancer

Affiliations

Validation of the Edmonton Symptom Assessment System in Korean patients with cancer

Jung Hye Kwon et al. J Pain Symptom Manage. 2013 Dec.

Abstract

Context: The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms.

Objectives: To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer.

Methods: We tested the K-ESAS in two pilot studies with 15 patients each. We assessed internal consistency, test-retest reliability, and concurrent validity in 163 Korean patients, who completed the K-ESAS along with the Korean versions of the M. D. Anderson Symptom Inventory (K-MDASI) and the Hospital Anxiety and Depression Scale (K-HADS) twice. A total of 38 patients completed the questionnaires again seven days later to assess responsiveness.

Results: The K-ESAS scores had good internal consistency, with a Cronbach's alpha coefficient of 0.88, indicating that no questions had undue influence on the score. Pearson correlation coefficients for K-ESAS symptom scores between baseline and after two to four hours ranged from 0.72 (95% CI 0.64-0.79) to 0.87 (95% CI 0.82-0.90), indicating strong test-retest reliability. For concurrent validity, Pearson correlation coefficients between K-ESAS symptom scores and corresponding K-MDASI symptom scores ranged from 0.70 (95% CI 0.62-0.77) to 0.83 (95% CI 0.77-0.87), indicating good concurrent validity. For the K-HADS, concurrent validity was good for anxiety (r=0.73, 95% CI 0.65-0.79) but moderate for depression (r=0.4, 95% CI 0.26-0.52). For responsiveness, changes in K-ESAS scores after seven days were moderately correlated with changes in K-MDASI scores but weakly correlated with changes in K-HADS scores.

Conclusion: The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer.

Keywords: Advanced cancer; ESAS; Edmonton Symptom Assessment System; Korea.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Validated Korean version of the Edmonton Symptom Assessment System.
Fig. 2
Fig. 2
Median changes in the K-ESAS scores after 7 (±1) days (n = 38).

Similar articles

Cited by

References

    1. Curtis EB, Krech R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliat Care. 1991;7:25–29. - PubMed
    1. Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;37:16–21. - PubMed
    1. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8:175–179. - PubMed
    1. Carvajal A, Centeno C, Watson R, Bruera E. A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer. 2011;47:1863–1872. - PubMed
    1. Stiel S, Matthes ME, Bertram L, et al. [Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative careý: the German version of the Edmonton Symptom Assessment Scale (ESAS)] [in German] Schmerz. 2010;24:596–604. - PubMed

Publication types

LinkOut - more resources